Carbapenem use in French hospitals: A nationwide survey at the patient level
Authors:
- 1 December 2015
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 46 (6) , 707-712
Abstract
No abstract availableKeywords
Funding Information
- Société de Pathologie Infectieuse de Langue Française (SPILF)
This publication has 13 references indexed in Scilit:
- Trial of Short-Course Antimicrobial Therapy for Intraabdominal InfectionNew England Journal of Medicine, 2015
- Predictive Value of Prior Colonization and Antibiotic Use for Third-Generation Cephalosporin-Resistant Enterobacteriaceae Bacteremia in Patients With SepsisClinical Infectious Diseases, 2015
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemasesThe Lancet Infectious Diseases, 2013
- Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2013
- Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care PatientsAntimicrobial Agents and Chemotherapy, 2013
- Risk associated with a systematic search of extended-spectrum β-lactamase–producing EnterobacteriaceaeAmerican Journal of Infection Control, 2013
- 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centreJournal of Antimicrobial Chemotherapy, 2012
- Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unitIntensive Care Medicine, 2012
- Point prevalence survey of antibiotic use in French hospitals in 2009Journal of Antimicrobial Chemotherapy, 2012
- -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective CohortsClinical Infectious Diseases, 2011